We are live on ! Find out more
IMNM icon

Immunome
IMNM

24 hedge funds and large institutions have $10.1M invested in Immunome in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

37% more capital invested

Capital invested by funds: $7.35M → $10.1M (+$2.75M)

0.11% less ownership

Funds ownership: 19.84% → 19.73% (-0.11%)

8% less funds holding

Funds holding: 26 → 24 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
24
Holders Change
-2
Holders Change %
-7.69%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
2
Closed
4
Calls
$231K
Puts
–
Net Calls
+$231K
Net Calls Change
+$84K

Top Buyers

1
UBS Group
UBS Group
Switzerland
+$65.4K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$14.8K
3
BlackRock
BlackRock
New York
+$10.5K
4
Group One Trading
Group One Trading
Illinois
+$10.4K
5
Simplex Trading
Simplex Trading
Illinois
+$7.87K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$61.7K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$56.5K
3
TC
Titleist Capital
Texas
-$32K
4
TRCT
Tower Research Capital (TRC)
New York
-$8K
5
Morgan Stanley
Morgan Stanley
New York
-$3.73K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
1
Prentice Capital Management
Connecticut
$3.52M – – –
AGM
2
Alpine Global Management
New York
$3.19M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.66M +$14.8K +3,149 +0.8%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$361K – – –
Cerity Partners
5
Cerity Partners
New York
$253K – – –
BlackRock
6
BlackRock
New York
$183K +$10.5K +2,241 +6%
State Street
7
State Street
Massachusetts
$131K – – –
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
$126K +$544 +116 +0.4%
MFG
9
Magnus Financial Group
New York
$114K – – –
SIAP
10
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$96K – – –
Renaissance Technologies
11
Renaissance Technologies
New York
$95K – – –
Neuberger Berman Group
12
Neuberger Berman Group
New York
$86K – – –
Northern Trust
13
Northern Trust
Illinois
$75K – – –
UBS Group
14
UBS Group
Switzerland
$68K +$65.4K +13,943 +1,050%
Morgan Stanley
15
Morgan Stanley
New York
$53K -$3.73K -796 -6%
WA
16
Wealth Architects
California
$49K – – –
Simplex Trading
17
Simplex Trading
Illinois
$16K +$7.87K +1,679 +86%
Group One Trading
18
Group One Trading
Illinois
$10K +$10.4K +2,228 +4,642%
Wells Fargo
19
Wells Fargo
California
$8K -$5 -1 -0.1%
Osaic Holdings
20
Osaic Holdings
Arizona
$5K +$5.76K +1,229 New
NFSG
21
Newbridge Financial Services Group
Florida
$2K – – –
Bank of Montreal
22
Bank of Montreal
Ontario, Canada
$529 – – –
BNP Paribas Financial Markets
23
BNP Paribas Financial Markets
France
$297 +$314 +67 New
BIM
24
Baldwin Investment Management
Pennsylvania
$113 – – –
Citadel Advisors
25
Citadel Advisors
Florida
– -$61.7K -13,159 Closed
1
2

IMNM Hedge Fund Activity: Q3 2022 in Review

24 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Immunome (IMNM) for Q3 2022, worth a combined $10.1M — up 37% from $7.35M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of IMNM and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 6 added.

The largest buyer was UBS Group, adding an estimated $65.4K. The largest seller was Citadel Advisors, exiting entirely with an estimated $61.7K sold.

  • 24 institutional investors held Immunome (IMNM) as of Q3 2022, down from 26 in Q2 2022.
  • Funds reported $10.1M of Immunome stock for Q3 2022, up 37% quarter-over-quarter.
  • 2 funds opened new Immunome positions in Q3 2022 and 4 closed out, a net change of -2 holders.
  • The largest Immunome buyer in Q3 2022 was UBS Group, an estimated $65.4K added.
  • The largest Immunome seller in Q3 2022 was Citadel Advisors, an estimated $61.7K sold.

Based on aggregated 13F filings for Q3 2022.